Ryuichi Morishita
Osaka University
708 Papers
8.1K Citations
Ryuichi Morishita is an academic researcher from Osaka University. The author has contributed to research in topics: Hepatocyte growth factor & Medicine. The author has an hindex of 86, co-authored 676 publications. Previous affiliations of Ryuichi Morishita include Brigham and Women's Hospital & Stanford University.
Chat about Author
Papers
HMG-Co A Reductase Inhibitors in the Treatment of Cardiovascular Diseases: Stabilization of Coronary Artery Plaque
TL;DR: Reports on pleiotropic activities of statins have accumulated to suggest an extended role of statin, not merely as a hypolipidemic agent but also possibly an anti-arteriosclerotic/anti-aging drug.
12
Egr-1 in vascular smooth muscle cell proliferation in response to allo-antigen.
Yuko Wada,Minoru Fujimori,Jun-ichi Suzuki,Katsuaki Tsukioka,Ken-ichi Ito,Yoshiki Sawa,Ryuichi Morishita,Yasufumi Kaneda,Mitsuaki Isobe,Jun Amano +9 more
TL;DR: Egr-1 plays an important role in the formation of the cardiac allograft vasculopathy responding to alloantigens and significantly suppressed intimal thickening of coronary arteries in a mixed cell culture model.
12
Development of new screening system for Alzheimer disease, in vitro Aβ sink assay, to identify the dissociation of soluble Aβ from fibrils
Naoyuki Sato,Masayasu Okochi,Yoshiaki Taniyama,Hitomi Kurinami,Munehisa Shimamura,Daisuke Takeuchi,Hizuki Hamada,Akio Fukumori,Kazuyuki Kiyosue,Takahisa Taguchi,Toshiyuki Tanaka,Masayuki Miyasaka,Masatoshi Takeda,Toshio Ogihara,Ryuichi Morishita +14 more
TL;DR: It is proposed that Abeta42 was more resistant to dissociation from fibrils to monomers and/or LMW soluble oligomers than Abeta40, and this system might be useful to identify dissociation of soluble Abeta fromfibrils.
12
Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element.
Yoshimi Saito,Hironori Nakagami,Masayuki Kurooka,Yoichi Takami,Yasushi Kikuchi,Hiroki Hayashi,Tomoyuki Nishikawa,Katsuto Tamai,Ryuichi Morishita,Nobuyoshi Azuma,Tadahiro Sasajima,Yasufumi Kaneda +11 more
TL;DR: Data suggest that expression of CSDA can repress angiogenesis and lymphangiogenesis via direct binding to SRE in addition to HRE, which may lead to growth inhibition in ECs.
12
Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study.
Ken Sugimoto,Tomohiro Katsuya,Kei Kamide,Tomomi Fujisawa,Izumi Shimaoka,Mitsuru Ohishi,Ryuichi Morishita,Toshio Ogihara,Hiromi Rakugi +8 more
TL;DR: BP change showed a significant interaction between the A-638G polymorphism of Regulator of G protein signaling-2 (RGS2) gene and treatment with azelnidipine or temocapril, which could be a predictive factor for therapeutic performance of Ca channel blockers.